Enhanced Therapeutic Effect of HSV-tk+GCV Gene Therapy and Ionizing Radiation for Prostate Cancer-Reference-Cited by-同舟云学术

Enhanced Therapeutic Effect of HSV-tk+GCV Gene Therapy and Ionizing Radiation for Prostate Cancer

Published:2001-04 Issue:4 Volume:3 Page:536-542
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Chhikara Madhu,Huang Hanxian,Vlachaki Maria T.,Zhu Xiaohong,Teh Bin,Chiu Kam J.,Woo Shiao,Berner Barry,Smith E.O'Brian,Oberg Kerby C.,Aguilar Laura K.,Thompson Timothy C.,Butler E.Brian,Aguilar-Cordova Estuardo

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference24 articles.

1. Urologic surgery;Dalkin,1996

2. Prostate-specific antigen and radiation therapy for clinically localized prostate cancer;Zagars;Int. J. Radiat. Oncol. Biol. Phys.,1995

3. Radical radiation therapy in the management of prostatic adenocarcinoma: The initial prostate specific antigen value as a predictor of treatment outcome;Zietman;J. Urol.,1994

4. Prostrate cancer gene therapy: Herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models;Eastham;Hum. Gene Ther.,1996

5. In situ gene therapy for adenocarcinoma of the prostate: A phase I clinical trial;Herman;Hum. Gene Ther.,1999

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What should be the future direction of development in the field of prostate cancer with lung metastasis?;World Journal of Clinical Oncology;2023-10-24

2. Targeted Radiation and Immune Therapies—Advances and Opportunities for the Treatment of Prostate Cancer;Pharmaceutics;2023-01-11

3. Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma;Molecular Therapy - Oncolytics;2022-09

4. A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer;Clinical Cancer Research;2022-07-25

5. Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models;Journal for ImmunoTherapy of Cancer;2022-01